Related Experiment Videos
Clinical infections and multiple sclerosis: contribution from analytical epidemiology
1Clinica Neurologica, Universitaă degli Studi di Ferraa, Ferrara, Italy.
Journal of Neurovirology
|June 29, 2000
Summary
Environmental factors, potentially viral, may influence multiple sclerosis (MS) development. While common childhood illnesses showed no difference, MS patients reported later infection ages, particularly for measles, rubella, mumps, and Epstein-Barr virus (EBV).
Area of Science:
- Neurology
- Epidemiology
- Infectious Diseases
Background:
- Multiple sclerosis (MS) etiology is complex, with epidemiological studies suggesting a role for exogenous, potentially viral, environmental factors.
- Existing evidence remains insufficient to definitively link specific viruses to MS development.
- Case-control studies have not yielded conclusive results regarding infectious agents and MS.
Purpose of the Study:
- To explore the potential association between viral infections and the etiology of multiple sclerosis.
- To investigate if specific infection timings or types correlate with MS development.
Main Methods:
- Review of epidemiological studies examining environmental factors in MS.
- Analysis of case-control data comparing infection frequencies and ages between MS patients and controls.
- Examination of data on common childhood illnesses, including measles, rubella, mumps, and Epstein-Barr virus (EBV) infections.
Main Results:
- No significant difference in the frequency of common childhood illnesses was observed between MS cases and controls.
- MS patients consistently reported a later age of onset for certain infections, notably measles, rubella, mumps, and EBV.
- Evidence suggests that viral or bacterial infections, or their reactivation, can precipitate clinical attacks in relapsing-remitting MS.
Conclusions:
- While a definitive viral cause for MS remains unproven, a later age at infection, particularly for measles, rubella, mumps, and EBV, is a consistent finding in MS patients.
- Infections and their reactivation are implicated as potential triggers for clinical relapses in relapsing-remitting MS.